(Q33881971)

29 July 2017

0 references

BRCA1 mutations do not increase prostate cancer risk: results from a meta-analysis including new data (English)

1 reference

29 July 2017

author

Antonio Gómez-Caamaño

object named as

Antonio Gómez-Caamaño

2

0 references

Laura Fachal

object named as

Laura Fachal

1

0 references

Ángel Carracedo

object named as

Angel Carracedo

8

0 references

author name string

Catuxa Celeiro-Muñoz

3

1 reference

29 July 2017

Paula Peleteiro

4

1 reference

29 July 2017

Ana Blanco

5

1 reference

29 July 2017

Ana Carballo

6

1 reference

29 July 2017

Jerónimo Forteza

7

1 reference

29 July 2017

Ana Vega

9

1 reference

29 July 2017

language of work or name

1 reference

25 April 2011

1 reference

29 July 2017

1 reference

29 July 2017

volume

71

1 reference

29 July 2017

issue

16

1 reference

29 July 2017

page(s)

1768-1779

1 reference

29 July 2017

cites work

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21394

Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21394

Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21394

Familial prostate cancer in Sweden. A nationwide register cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21394

Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21394

A common variant associated with prostate cancer in European and African populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21394

A common 8q24 variant in prostate and breast cancer from a large nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21394

Two variants on chromosome 17 confer prostate cancer risk and the one in TCF2 protects against type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21394

Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21394

Multiple regions within 8q24 independently affect risk for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21394

Genome-wide association study of prostate cancer identifies a second risk locus at 8q24

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21394

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21394

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21394

Cancer Incidence in BRCA1 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21394

Cancer risks among BRCA1 and BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21394

Germline BRCA mutations denote a clinicopathologic subset of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21394

Founder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21394

The Jewish Ashkenazi founder mutations in the BRCA1/BRCA2 genes are not found at an increased frequency in Ashkenazi patients with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21394

Common mutations in BRCA1 and BRCA2 do not contribute to early prostate cancer in Jewish men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21394

The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21394

BRCA mutations and risk of prostate cancer in Ashkenazi Jews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21394

Associations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21394

BRCA1 mutations and prostate cancer in Poland

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21394

The R71G BRCA1 is a founder Spanish mutation and leads to aberrant splicing of the transcript

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21394

Haplotype and quantitative transcript analyses of Portuguese breast/ovarian cancer families with the BRCA1 R71G founder mutation of Galician origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21394

Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21394

BRCA1 and BRCA2 mutations have no major role in predisposition to prostate cancer in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21394

Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21394

BRCA1 and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21394

Prevalent mutations in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21394

Common variation in the BRCA1 gene and prostate cancer risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21394

Absence of 185delAG mutation of the BRCA1 gene and 6174delT mutation of the BRCA2 gene in Ashkenazi Jewish men with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21394

A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21394

BRCA1 and BRCA2 founder mutations and the risk of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21394

The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21394

The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21394

21 January 2018

Identifiers

DOI

10.1002/PROS.21394

1 reference

29 July 2017

1 reference